Science watch

Our science watch section reports on the story behind the media-reported “breakthrough” headlines in dementia, by focusing on the original journal study. Reports of other developments in research on care and cure are also included.

22/01/2019		Study investigates link between frailty and AD dementia
16/01/2019		United Neuroscience announces results from Phase II study of UB-311 vaccine in people with AD
14/01/2019		Researchers suggest that blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction
09/01/2019		Sirion and Denali announce collaboration to develop gene therapies for neurodegenerative diseases
09/01/2019		Study suggests that alterations in NREM sleep is associated with early signs of AD
08/01/2019		Study on evidence-based medication review finds consensus to be helpful to lower psychotropic drug prescription
07/01/2019		Study assesses racial disparities in Biomarkers for AD
07/01/2019		Scientists publish paper on new genetic risk factors for AD
04/01/2019		Study investigates potentially inappropriate prescribing in older people with dementia
27/12/2018		Study supports genetic diversity in AD mouse models introducing a new population for preclinical research
13/12/2018		Scientists teamed up to publish major multicentre study on subjective cognitive decline and rates of incident AD and dementia
13/12/2018		The ISTAART society publishes white paper to advance research on dementia across ethnoracial populations
12/12/2018		Eli Lilly and AC Immune sign a collaboration agreement to develop new treatments for AD
10/12/2018		Axsome Therapeutics announces outcomes of interim analysis of its AD agitation drug
10/12/2018		Axovant Sciences announces results of its Phase II study in people with LBD experiencing rapid eye movement sleep behavior disorder

 

Next » 1 2 3 4 5 ...106